From Gene to Genomics and Epigenomics: The Future of Cancer Precision Medicine

DNA Double Helix
Share this event

Gairdner Science Week Symposium

Featuring 2021 Canada Gairdner Award Laureates Mary-Claire King and Elizabeth Eisenhauer, and international research leaders Charles Swanton (Francis Crick Institute, UK), Sam Aparicio (UBC, Canada), Nada Jabado (McGill, Canada) and others.


12:00 pm Introduction & Welcome

Dr. Janet Rossant, President & Scientific Director, The Gairdner Foundation  

Session 1. Chair: Dr. Jim Woodgett, Terry Fox Research Institute

12:05 pm How Heritable Cancer Mutations Inform All Cancer Treatments.

Dr. Mary-Claire King, 2021 Canada Gairdner International Award laureate; University of Washington, Seattle, Washington, USA

12:25 pm  Tumour Heterogeneity and Tumour Evolution.

Dr. Charles Swanton, The Francis Crick Institute, London, United Kingdom

12:45 pm Molecular Taxonomy of Breast Cancer and Next-Generation Treatments.

Dr. Sam Aparicio, University of British Columbia, Vancouver, British Columbia Canada

1:05 pm Cancer Epigenetics, Early Detection and Epigenetic Therapies.

Dr. Daniel De Carvalho, Princess Margaret Cancer Centre; the University of Toronto, Toronto, Ontario, Canada

1:25 pm   BREAK

Session 2. Chair: Dr. Lillian Siu, Princess Margaret Cancer Centre, UHN, Toronto.

1:40 pm   Genetics and Epigenetics of Childhood Brain Tumours.

Dr. Nada Jabado, McGill University, Montreal, Quebec, Canada

2:00 pm Cycling Cancer Persister Cells: Lineage Relationships and Non-genetic Mechanisms.

Dr Aviv Regev, Genentech, South San Francisco, California.

2:20 pm Driving Innovation and Partnerships in Canadian Clinical Trials.

Dr. Elizabeth Eisenhauer, 2021 Canada Gairdner Wightman Award laureate; Queen’s University, Kingston, Ontario, Canada

2:40 pm Roundtable Discussion With All Speakers

Moderated by Dr. Victor Ling.

3:30 pm Event concludes